The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...
23andMe (ME), the company that popularized at-home DNA tests ... to ensure the long-term success of the business as we ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...
The genetics company is closing a unit that was once seen as core to its future.
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback